Fig. 4.
Fig. 4. TGF-β expression in spleen section from mice engrafted with WT or TGF-β1−/−virus–infected hematopoietic cells. / Immunocytochemistry using a TGF-β–specific antibody (A,B). Immunostaining specificity was checked by omitting the primary antibody (C,D). Representative sections are shown at 3 months after transplantation. (A) Mouse engrafted with WT cells showing strong positivity in MK and granulocytes. (B) Mouse engrafted with TGF-β1−/− cells showing no immunoreactivity. (C,D) No immunostaining was revealed when the primary antibody was omitted. Original magnification, × 600 for all panels.

TGF-β expression in spleen section from mice engrafted with WT or TGF-β1−/−virus–infected hematopoietic cells.

Immunocytochemistry using a TGF-β–specific antibody (A,B). Immunostaining specificity was checked by omitting the primary antibody (C,D). Representative sections are shown at 3 months after transplantation. (A) Mouse engrafted with WT cells showing strong positivity in MK and granulocytes. (B) Mouse engrafted with TGF-β1−/− cells showing no immunoreactivity. (C,D) No immunostaining was revealed when the primary antibody was omitted. Original magnification, × 600 for all panels.

Close Modal

or Create an Account

Close Modal
Close Modal